Search Results - "SHARPLESS, Julie L"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin by McCudden, Christopher R., Sharpless, Julie L., Grenache, David G.

    Published in Clinica chimica acta (01-02-2010)
    “…Macroprolactin is a large, heterogeneous form of prolactin with limited bioavailability. Detection of macroprolactin by different immunoassays varies widely…”
    Get full text
    Journal Article
  2. 2

    Testosterone Lab Testing and Initiation in the United Kingdom and the United States, 2000 to 2011 by Layton, J. Bradley, Li, Dongmei, Meier, Christoph R, Sharpless, Julie L, Stürmer, Til, Jick, Susan S, Brookhart, M. Alan

    “…Context: New formulations, increased marketing, and wider recognition of declining testosterone levels in older age may have contributed to wider testosterone…”
    Get full text
    Journal Article
  3. 3

    Comparative Safety of Testosterone Dosage Forms by Layton, J Bradley, Meier, Christoph R, Sharpless, Julie L, Stürmer, Til, Jick, Susan S, Brookhart, M Alan

    Published in JAMA internal medicine (01-07-2015)
    “…Increases in testosterone use and mixed reports of adverse events have raised concerns about the cardiovascular safety of testosterone. Testosterone is…”
    Get more information
    Journal Article
  4. 4

    Metachronous Bilateral Testicular Leydig-Like Tumors Leading to the Diagnosis of Congenital Adrenal Hyperplasia (Adrenogenital Syndrome) by Milowsky, Matthew I., Raynor, Mathew C., Sharpless, Julie L., Chism, David D., Vukina, Josip, Funkhouser, William K.

    Published in Case reports in pathology (01-01-2015)
    “…A 33-year-old male with a history of left testis Leydig cell tumor (LCT), 3-month status after left radical orchiectomy, presented with a rapidly enlarging…”
    Get full text
    Journal Article
  5. 5

    Injection testosterone and adverse cardiovascular events: A case‐crossover analysis by Layton, J. Bradley, Li, Dongmei, Meier, Christoph R., Sharpless, Julie L., Stürmer, Til, Brookhart, M. Alan

    Published in Clinical endocrinology (Oxford) (01-05-2018)
    “…Summary Context Exogenous testosterone administration may affect blood clotting, polycythaemia, and may increase atherosclerosis, though any association with…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Quality of life after long-term biochemical control of acromegaly by Kimball, Allison, Dichtel, Laura E., Yuen, Kevin C. J., Woodmansee, Whitney W., Haines, Melanie S., Nachtigall, Lisa B., Swearingen, Brooke, Jones, Pamela, Tritos, Nicholas A., Sharpless, Julie L., Kaiser, Ursula B., Gerweck, Anu, Miller, Karen K.

    Published in Pituitary (01-06-2022)
    “…Purpose To assess long-term quality of life (QoL) in patients with sustained biochemical control of acromegaly, comparing those receiving vs not receiving…”
    Get full text
    Journal Article
  8. 8

    Predictors and incidence of central diabetes insipidus after endoscopic pituitary surgery by Sigounas, Dimitri G, Sharpless, Julie L, Cheng, D Ming L, Johnson, Tiffany G, Senior, Brent A, Ewend, Matthew G

    Published in Neurosurgery (01-01-2008)
    “…With the advent of minimally invasive endoscopic pituitary surgery, there has been concern that the technique may be associated with higher rates of…”
    Get full text
    Journal Article
  9. 9

    Polycystic Ovary Syndrome and the Metabolic Syndrome by Sharpless, Julie L.

    Published in Clinical diabetes (01-10-2003)
    “…Polycystic Ovary Syndrome and the Metabolic Syndrome Julie L. Sharpless , MD Abstract In Brief Many patients with polycystic ovary syndrome (PCOS) also have…”
    Get full text
    Journal Article
  10. 10

    Effects of short-term hormone replacement on serum leptin levels in postmenopausal women by Lavoie, Helene B., Taylor, Ann E., Sharpless, Julie L., Anderson, Ellen J., Strauss, Carrie C., Hall, Janet E.

    Published in Clinical endocrinology (Oxford) (01-10-1999)
    “…OBJECTIVE Leptin is a hormone which is secreted by adipocytes and appears to influence the reproductive axis. Previous studies have demonstrated higher leptin…”
    Get full text
    Journal Article
  11. 11

    Osteoporosis: An Under-appreciated Complication of Diabetes by Brown, Sue A, Sharpless, Julie L

    Published in Clinical diabetes (22-12-2004)
    “…In Brief Care of patients with diabetes should include an assessment of bone health. It is now clear that patients with type 1 diabetes have lower bone mineral…”
    Get full text
    Journal Article
  12. 12

    Body composition and energy balance: Lack of effect of short-term hormone replacement in postmenopausal women by Anderson, Ellen J., Lavoie, Helene B., Strauss, Carrie C., Hubbard, Jane L., Sharpless, Julie L., Hall, Janet E.

    Published in Metabolism, clinical and experimental (01-03-2001)
    “…Postmenopausal women (PMW) commonly believe that hormone replacement (HR) leads to weight gain, and fear of weight gain and/or an actual increase in weight is…”
    Get full text
    Journal Article
  13. 13

    Evidence That GnRH Decreases with Gonadal Steroid Feedback but Increases with Age in Postmenopausal Women by Gill, Sabrina, Sharpless, Julie L., Rado, Kimberly, Hall, Janet E.

    “…Studies of the effects of gonadal steroid negative feedback and age on the hypothalamic-pituitary axis in postmenopausal women (PMW) have identified…”
    Get full text
    Journal Article
  14. 14

    Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women by GILL, Sabrina, SHARPLESS, Julie L, RADO, Kimberly, HALL, Janet E

    “…Studies of the effects of gonadal steroid negative feedback and age on the hypothalamic-pituitary axis in postmenopausal women (PMW) have identified…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Osteoporosis: An Under-appreciated Complication of Diabetes by Sue A. Brown, Julie L. Sharpless, Y E Granfeldt, I E Björck, N G Asp, B O Vessby

    Published in Diabetes care (01-01-1999)
    “…Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. A E Järvi , B E…”
    Get full text
    Journal Article
  17. 17

    Disappearance of endogenous Luteinizing Hormone is prolonged in postmenopausal women by SHARPLESS, J. L, SUPKO, J. G, MARTIN, K. A, HALL, J. E

    “…Pituitary secretion of LH is increased after menopause, but it is not known whether changes in LH clearance also contribute to elevated serum levels. To…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Disappearance of Endogenous Luteinizing Hormone Is Prolonged in Postmenopausal Women1 by Sharpless, Julie L, Supko, Jeffrey G, Martin, Kathryn A, Hall, Janet E

    “…Pituitary secretion of LH is increased after menopause, but it is not known whether changes in LH clearance also contribute to elevated serum levels. To…”
    Get full text
    Journal Article